Citation Impact

Citing Papers

Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
The molecular mechanisms that control thrombopoiesis
2005
Efficacy of dendrimer‐mediated angiostatin and TIMP‐2 gene delivery on inhibition of tumor growth and angiogenesis: In vitro and in vivo studies
2003
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) at the Interface between Coagulation and Fibrinolysis
2003
Plasma carboxypeptidases as regulators of the plasminogen system.
1995
TAFI polymorphisms at amino acids 147 and 325 are not risk factors for cerebral infarction
2004 StandoutNobel
PROACT: A Phase II Randomized Trial of Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute Middle Cerebral Artery Stroke
1998
Intraluminal Thrombus has a Selective Influence on Matrix Metalloproteinases and Their Inhibitors (Tissue Inhibitors of Matrix Metalloproteinases) in the Wall of Abdominal Aortic Aneurysms
2012 StandoutNobel
Thrombin activatable fibrinolysis inhibitor (TAFI)—How does thrombin regulate fibrinolysis?
2006
Abdominal aortic aneurysm
2005 Standout
Regulation of Plasmin-dependent Fibrin Clot Lysis by Annexin II Heterotetramer
2001
Tranexamic Acid
1999 Standout
TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation
2011
Biomedical applications of biodegradable polymers
2011 Standout
Intra-arterial Prourokinase for Acute Ischemic Stroke
1999 Standout
Toxicity of cationic lipids and cationic polymers in gene delivery
2006 Standout
New insights into the molecular mechanisms of the fibrinolytic system
2008
2 Plasminogen activators and plasminogen activator inhibitors: biochemical aspects
1995
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times
1993
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
On the Mechanism of the Antifibrinolytic Activity of Plasma Carboxypeptidase B
1997
Designing dendrimers for biological applications
2005 Standout
Blood plasma coagulation studied by surface plasmon resonance
2000 StandoutNobel
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Involvement of the Mural Thrombus as a Site of Protease Release and Activation in Human Aortic Aneurysms
2002
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Effect of Anticoagulants in Colorimetric Assay for Basic Carboxypeptidases
2002 StandoutNobel
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development
2007 StandoutNobel
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Complement C5b-9 Increases Plasminogen Binding and Activation on Human Endothelial Cells
1997
Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not
2000 StandoutNobel
Annexin II Tetramer Inhibits Plasmin-Dependent Fibrinolysis
1998
Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation
1996
Thrombin Activatable Fibrinolysis Inhibitor and an Antifibrinolytic Pathway
2000
FIBRINOGEN AND FIBRIN-PROTEINS WITH COMPLEX ROLES IN HEMOSTASIS AND THROMBOSIS
1996
Inflammation and Cellular Immune Responses in Abdominal Aortic Aneurysms
2006 Standout
Inactivation of C3a and C5a Octapeptides by Carboxypeptidase R and Carboxypeptidase N
2002 StandoutNobel
Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
1992
Arginine Carboxypeptidase (CPR) in Human Plasma Determined with Sandwich ELISA
1999 StandoutNobel
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Annexins: From Structure to Function
2002 Standout
Binding of Tissue-Plasminogen Activator to Fibrin: Effect of Ultrasound
1998
Biodegradable Long-Circulating Polymeric Nanospheres
1994 StandoutScience
Rational Structure-Based Design of a Novel Carboxypeptidase R Inhibitor
2002 StandoutNobel
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
The Impact of Recanalization on Ischemic Stroke Outcome
2007 Standout
Procarboxypeptidase R Deficiency Causes Increased Lethality in Concanavalin A-Induced Hepatitis in Female Mice
2010 StandoutNobel
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma
1996
Molecular Cloning and Partial Characterization of Rat Procarboxypeptidase R and Carboxypeptidase N
2000 StandoutNobel
Assay of Procarboxypeptidase U, a Novel Determinant of the Fibrinolytic Cascade, in Human Plasma
1999

Works of V. Fleury being referenced

Characterization of the binding of plasminogen to fibrin surfaces: The role of carboxy-terminal lysines
1991
Molecular assembly of plasminogen and tissue‐type plasminogen activator on an evolving fibrin surface
1993
Apolipoprotein(a) and plasminogen interactions with fibrin: a study with recombinant apolipoprotein(a) and isolated plasminogen fragments
1992
A monoclonal antibody directed against an epitope in the NH2-terminal region of native human plasminogen induces a modification of its functional properties
1997
Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
1993
Human thrombopoietin structure–function relationships: identification of functionally important residues
1998
Rankless by CCL
2026